1 |
Sung H, Ferlay J, Siegel RL, et al.Global Cancer Statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].CA Cancer J Clin, 2021, 71(3): 209-249.
|
2 |
殷德涛, 鞠定吾.热消融在低危甲状腺微小乳头状癌治疗中的应用现状 [J].国际外科学杂志, 2022, 49(2): 73-78.
|
3 |
Haugen BR, Alexander EK, Bible KC, et al.2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cance [J].Thyroid, 2016, 26(1): 1-133.
|
4 |
Gharib H, Papini E, Garber JR, et al.American Association Of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi medical guideline for cilinical practice for the diagnosis and management of thyroid nodules-2016 update [J].Endocr Pract, 2016, 22(Suppl 1): 1-60.
|
5 |
中华医学会内分泌学分会, 中华医学会外科学分会内分泌学组,中国抗癌协会头颈肿瘤专业委员会, 等.甲状腺结节和分化型甲状腺癌诊治指南 [J/CD].中华核医学与分子影像杂志(电子版),2013, 33(2): 96-115.
|
6 |
章建全, 陈红琼, 闫磊, 等.对甲状腺结节细针穿刺有关问题的新思考 [J/OL].中华医学超声杂志(电子版), 2023, 20(10): 1007-1011.
|
7 |
中国医师协会超声医师分会.甲状腺微小乳头状癌热消融诊疗指证专家共识 [J/CD].中华医学超声杂志(电子版), 2019, 16(8): 571-574.
|
8 |
高明, 葛明华, 嵇庆海, 等.甲状腺微小乳头状癌诊断与治疗中国专家共识(2016 版) [J].中国肿瘤临床, 2016, 43(10): 405-411.
|
9 |
Lloyd RV, Osamura RY, Kloppel G, et al.WHO classification of tumours: pathology and genetics of tumours of endocrineorgans [M].4th ed.Lyon: IARC Press, 2017(10): 65-142.
|
10 |
许敏, 赵齐羽, 蒋天安.热消融在甲状腺癌治疗中的应用现状与争议 [J].中华超声影像学杂志, 2021, 30(11): 1007-1012.
|
11 |
颜燕煌, 林晶, 高子斌, 等.甲状腺微小乳头状癌144 例热消融范围探讨 [J].肿瘤学杂志, 2019, 25(10): 924-925.
|
12 |
Deveci MS, Deveci G, LiVolsi VA, et al.Concordance between thyroid nodule sizes measured by ultrasound and gross pathology examination:effect on patient management [J].Diagn Cytopathol,2007, 35(9): 579-583.
|
13 |
Bachar G, Buda I, Cohen M, et al.Size discrepancy between sonographic and pathological evaluation of solitary papillary thyroid carcinoma [J].Eur J Radiol, 2013, 82(11): 1899-1903.
|
14 |
Yoon YH, Kwon KR, Kwak SY, et al.Tumor size measured by preoperative ultrasonography and postoperative pathologic examination in papillarythyroid carcinoma:relative differences according to size, calcification and coexisting thyroiditis [J].Eur Arch Otorhinolaryngol, 2014, 271(5): 1235-1239.
|
15 |
丁金旺, 韩志江, 张卧, 等.甲状腺结节超声纵横比与大体组织纵横比的对照研究 [J].中国临床医学影像杂志, 2016, 27(5): 337-340.
|
16 |
王颖, 丁金旺, 韩志江, 等.超声检查和病理测量甲状腺乳头状癌肿瘤大小的对比研究[J].中国耳鼻咽喉头颈外科, 2017, 24(3):149-152.
|
17 |
Choi SH, Kim EK, Kwak JY, et al.Interobserver and intraobserver variations in ultrasound assessment of thyroid nodules [J].Thyroid,2010, 20(2): 167-172.
|
18 |
Kshithi K, Kamboj V, Sreedharan S, et al.Effect of formalin fixation on tumour size and margins in head and neck cancer specimens [J].Acta Otorhinolaryngol Ital, 2022, 42(5): 434-440.
|
19 |
王万菊, 张冬, 刘放, 等.微小钙化及纵横比大于1 在TI-RADS 4 类甲状腺结节中的诊断价值 [J].中国现代普通外科进展, 2022,25(5): 356-361.
|
20 |
王帅, 徐辉雄, 徐军妹, 等.甲状腺结节微钙化、粗大钙化及环状钙化与甲状腺癌的相关性分析 [J].影像诊断与介入放射学, 2015,24(3): 212-215.
|
21 |
Oh EM, Chung YS, Song WJ, et al.The pattern and significance of the calcifications of papillary thyroid microcarcinoma presented in preoperative neck ultrasonography [J].Ann Surg Treat Res, 2014,86(3): 115-121.
|
22 |
Pyo JS, Kang G, Kim DH, et al.The prognostic relevance of psammoma bodies and ultrasonographic intratumoral calcifications in papillary thyroid carcinoma [J].World J Surg, 2013, 37(10): 2330-2335.
|
23 |
李晶, 姜罗, 史铁梅.乳腺癌超声恶性晕病理基础 [J].中华超声影像学杂志, 2012, 21(9): 787-790.
|
24 |
吴剑, 杨湛.肿瘤浸润前沿细胞的生物学特性 [J].医学综述, 2007,13(13): 986-988.
|
25 |
白艳花, 薛卫成.甲状腺乳头状癌的组织学特点、分子标志物表达与临床预后的关系 [J].中华病理学杂志, 2014, 43(5): 341-343.
|
26 |
Jin H, Yan H, Tang H, et al.Internal spreading of papillary thyroid carcinoma: a case report and systemic review [J].Case Rep Endocrinol, 2018, 2018: 7618456.
|
27 |
Pancer J, Mitmaker E, Ajise O, et al.A thyroid gland with over 30 foci of papillary thyroid carcinoma with activating BRAF V600E mutation[J].Endocrinol Diabetes Metab Case Rep, 2019, 2019: 19-0006.
|
28 |
Lei Y, Feng S, Yu Q, et al.Conventional papillary thyroid carcinoma with intraglandular lymphatic dissemination shows more aggressive features [J].Jpn J Clin Oncol, 2022, 52(11): 1311-1320.
|
29 |
Fang H, Si Y, Wang C, et al.Diffuse intrathyroidal dissemination of papillary thyroid carcinoma with no stromal fibrosis at presentation: A pattern of aggressive differentiated thyroid carcinoma [J].Pathol Res Pract, 2021, 224: 153510.
|